We hypothesized that elevated levels of the effectors we observe in mice lacking MMP17, might offer an advantage in clearing intestinal infections, as both ANG4 and RELM-β have been described to have anti-bacterial properties (11, 14). Here, MMP17 is linked to digestive system infectious disorder.